296 related articles for article (PubMed ID: 21527584)
21. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
[TBL] [Abstract][Full Text] [Related]
22. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.
Vendrame E; Martínez-Maza O
J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858
[TBL] [Abstract][Full Text] [Related]
23. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
[TBL] [Abstract][Full Text] [Related]
24. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.
Wong HL; Breen EC; Pfeiffer RM; Aissani B; Martinson JJ; Margolick JB; Kaslow RA; Jacobson LP; Ambinder RF; Chanock S; Martínez-Maza O; Rabkin CS
AIDS; 2010 Apr; 24(7):1025-33. PubMed ID: 20299965
[TBL] [Abstract][Full Text] [Related]
25. Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies.
Makgoeng SB; Bolanos RS; Jeon CY; Weiss RE; Arah OA; Breen EC; Martínez-Maza O; Hussain SK
JNCI Cancer Spectr; 2018 Dec; 2(4):pky082. PubMed ID: 30873511
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys.
Hannig H; Buske C; Mätz-Rensing K; Hunsmann G; Hiddemann W; Bodemer W
Int J Cancer; 1998 Aug; 77(5):734-40. PubMed ID: 9688307
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F
AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712
[TBL] [Abstract][Full Text] [Related]
28. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
[TBL] [Abstract][Full Text] [Related]
30. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue.
Schroeder JR; Saah AJ; Ambinder RF; Martinez-Maza O; Crabb Breen E; Variakojis D; Margolick JB; Jacobson LP; Rowe DT; Hoover DR
Clin Immunol; 1999 Dec; 93(3):239-44. PubMed ID: 10600334
[TBL] [Abstract][Full Text] [Related]
31. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.
Breen EC; van der Meijden M; Cumberland W; Kishimoto T; Detels R; Martínez-Maza O
Clin Immunol; 1999 Sep; 92(3):293-9. PubMed ID: 10479534
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.
Siewe B; Pham JT; Cohen M; Hessol NA; Levine A; Martinez-Maza O; Landay A
AIDS; 2015 Aug; 29(13):1659-64. PubMed ID: 26372276
[TBL] [Abstract][Full Text] [Related]
33. Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.
Epeldegui M; Martínez-Maza O
For Immunopathol Dis Therap; 2015; 6(1-2):79-90. PubMed ID: 28702272
[TBL] [Abstract][Full Text] [Related]
34. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.
Epeldegui M; Vendrame E; Martínez-Maza O
Immunol Res; 2010 Dec; 48(1-3):72-83. PubMed ID: 20717742
[TBL] [Abstract][Full Text] [Related]
35. Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.
Bassig BA; Shu XO; Koh WP; Gao YT; Purdue MP; Butler LM; Adams-Haduch J; Xiang YB; Kemp TJ; Wang R; Pinto LA; Zheng T; Ji BT; Hosgood HD; Hu W; Yang G; Zhang H; Chow WH; Kim C; Seow WJ; Zheng W; Yuan JM; Lan Q; Rothman N
Int J Cancer; 2015 Dec; 137(11):2688-95. PubMed ID: 26095604
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.
Levin LI; Ramirez CM; Liao EL; Guo H; Kim BK; Marrogi AJ; Magpantay LI; Breen EC; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):233-241. PubMed ID: 36409490
[TBL] [Abstract][Full Text] [Related]
37. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
38. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
Diamond C; Taylor TH; Im T; Anton-Culver H
Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
[TBL] [Abstract][Full Text] [Related]
39. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
[TBL] [Abstract][Full Text] [Related]
40. Current perspectives on cytokines for anti-retroviral therapy in AIDS related B-cell lymphomas.
Sharma V
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):137-49. PubMed ID: 12769791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
